# OnCo record gamma-biotherapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/gamma-biotherapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "gamma-biotherapeutics" ;
  schema:name "Gamma Biotherapeutics"@en ;
  schema:alternateName "GAMMA BIOTHERAPEUTICS, INC."@en ;
  schema:description "Gamma Biotherapeutics is a Portland company whose antibody, M3T01, blocks Fas ligand, a molecule many tumours use to kill the T cells that attack them. It is in an early trial in people with advanced cancers."@en ;
  schema:url <https://onco.cc/companies/gamma-biotherapeutics/>, <https://www.gammabiotherapeutics.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.gammabiotherapeutics.com/>, <https://clinicaltrials.gov/study/NCT06719362>, <https://reporter.nih.gov/project-details/11315901> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:drugs <https://onco.cc/drugs/m3t01/> .
